Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 616

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 616
---
-8176, Japan. West 55th                                                                                                             
 Street, Suite 30A, New York, New York 10019.                                                                                                                                                                                        |

| (13) | This information is based solely on a Schedule 13G filed by TD Securities (USA) LLC, Cowen Financial Products                                                                                                                              
 LLC, TD Group US Holdings LLC, Toronto Dominion Bank and Toronto Dominion Holdings Bank (the “TD Reporting Persons”) with the SEC on December 26, 2024. TD Securities (USA) LLC has sole voting power of 30,000 shares and Cowen Financial 
 Products LLC has sole voting power of 50,000 shares. The number of shares held by the TD Reporting Persons is reported as of December 16, 2024, as stated in the Schedule 13G, which does not reflect any redemption of shares by the TD   
 Reporting Persons in connection with the Business Combination itself, or any other transactions after December 16, 2024. The business address of such holder is One Vanderbilt Avenue, New York, New York 10017.                           |

390

DESCRIPTION OF DENALI’S SECURITIES

Unless the context otherwise requires, for purposes of this section, the terms “we,” “us,” “our,” “the Company” or “Denali” refer to Denali Capital Acquisition Corp. prior to the consummation of the Business Combination.

As of
March 17, 2023, Denali had the following three classes of its securities registered under Section 12 of the Exchange Act: (i) Denali Class A Ordinary Shares, (ii) redeemable Warrants, each whole warrant exercisable for one
Denali Class A Ordinary Share at an exercise price of $11.50 per share, subject to adjustment, and (iii) Units, consisting of one Denali Class A Ordinary Share and one redeemable warrant to purchase one Denali Class A Ordinary
Share.

We are a Cayman Islands exempted company and our affairs are governed by our amended and restated memorandum and articles of association, the
Companies Act and the common law of the Cayman Islands. Pursuant to our amended and restated memorandum and articles of association, we are authorized to issue 200,000,000 Denali Class A Ordinary Shares, $0.0001 par value, and 20,000,000 Denali
Class B Ordinary Shares, $0.0001 par value, as well as 1,000,000 preference shares, $0.